Daily Archives: May 16, 2011

Know your epidemiology: one lesson of many for GeneXpert roll-out

By on .

In this guest blog post, Sophie Beauvais of the Global Health Delivery Project at Harvard University, and Chris Gilpin from the WHO’s Stop TB Department, summarize the ongoing virtual panel discussion on the feasibility of implementing the Xpert MTB/RIF in limited-resource settings. Discussion so far is highlighting the critical importance of understanding the local epidemiology for tuberculosis (TB), especially for multidrug-resistant TB (MDR-TB) and also for HIV-associated TB. Prioritizing these two risk groups in diagnostic algorithms that use the Xpert MTB/ RIF as the initial diagnostic test is a key message for the efficient integration of this new tool into existing health systems. But it is by no means the only key message. Read More…

Simpler treatment option for latent TB, tinkering with tenofovir to lower drug costs, and more…

By on .

The following is a compilation of recent articles and news pieces making headlines in HIV/TB and global health. Research offers simpler, effective treatment option for latent TB infection: New research from the Centers for Disease Control and Prevention (CDC) shows that a supervised, three-month regimen of rifampentine and isoniazid for the treatment of latent tuberculosis […]